Testing Potential Developmental Toxicants with a Cytotoxicity Assay Based on Human Embryonic Stem Cells

Since the differentiation of embryonic stem cells mimics early development, these cells could potentially permit the detection of embryotoxicants which interfere with this process. Although reliable tests based on murine embryonic stem cells exist, no such methods are available for human embryonic stem (hES) cells. Nonetheless, to avoid the false classification of substances due to inter-species differences, human-relevant toxicity tests are needed. We therefore developed an assay based on three human cell types, representing different degrees of developmental maturation, namely, human foreskin fibroblasts, hES cell-derived progenitor cells, and pluripotent hES cells. A set of embryotoxicants for which existing in vivo data were available, namely, all-trans retinoic acid (ATRA), 13-cis retinoic acid (13CRA), valproic acid (VPA) and dimethyl sulphoxide (DMSO), were tested. 5-fluorouracil (5-FU) was used as a positive control, and saccharin as a negative control. Two methods were compared for the assessment of cell viability — the determination of intracellular ATP content and of resazurin reduction. In addition, the protective capacity of basic fibroblast growth factor (bFGF) against retinoid-induced toxicity was investigated. This novel assay system reliably detected the embryotoxic potentials of the test substances, 5-FU, ATRA, 13-CRA (a substance that displays inter-species differences in its effects) and VPA. This was possible due to the apparent differences in the sensitivities of the human cell types used in the assay system. Thus, our results clearly indicate the advantages and relevance of using hES cells in in vitro developmental toxicity testing.

[1]  C. Zouboulis,et al.  All-trans-Retinoic Acid and 13-cis-Retinoic Acid: Pharmacokinetics and Biological Activity in Different Cell Culture Models of Human Keratinocytes , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[2]  Sujin Kwon,et al.  Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells. , 2006, Biochemical and biophysical research communications.

[3]  D. Thiboutot,et al.  13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. , 2006, The Journal of investigative dermatology.

[4]  T Hartung,et al.  The effects of solvents on embryonic stem cell differentiation. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[5]  H. Groen,et al.  Genetic factors influencing Pyrimidine-antagonist chemotherapy , 2005, The Pharmacogenomics Journal.

[6]  Angel W. Lee,et al.  A novel role for Gab2 in bFGF-mediated cell survival during retinoic acid–induced neuronal differentiation , 2005, The Journal of cell biology.

[7]  T. Hartung,et al.  The Detection of Differentiation-inducing Chemicals by using Green Fluorescent Protein Expression in Genetically Engineered Teratocarcinoma Cells , 2005, Alternatives to laboratory animals : ATLA.

[8]  Jeanette Wiltse,et al.  Mode of Action: Inhibition of Histone Deacetylase, Altering WNT-Dependent Gene Expression, and Regulation of Beta-Catenin—Developmental Effects of Valproic Acid , 2005, Critical reviews in toxicology.

[9]  Susanne Bremer,et al.  Validation of the Embryonic Stem Cell Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests , 2004, Alternatives to laboratory animals : ATLA.

[10]  T Hartung,et al.  The use of embryonic stem cells for regulatory developmental toxicity testing in vitro--the current status of test development. , 2004, Current pharmaceutical design.

[11]  M E Hurtt,et al.  Proposal for a tiered approach to developmental toxicity testing for veterinary pharmaceutical products for food-producing animals. , 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[12]  J. Curtin,et al.  Retinoid target gene activation during induced tumor cell differentiation: human embryonal carcinoma as a model. , 2003, The Journal of nutrition.

[13]  N. Brown.  Selection of Test Chemicals for the ECVAM International Validation Study on In Vitro Embryotoxicity Tests , 2002, Alternatives to laboratory animals : ATLA.

[14]  H Nau,et al.  Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid. , 2001, Journal of the American Academy of Dermatology.

[15]  M. Tolomeo,et al.  Retinoids, apoptosis and cancer. , 2001, Current pharmaceutical design.

[16]  C. Westmoreland,et al.  Development of a high throughput in vitro toxicity screen predictive of high acute in vivo toxic potential. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[17]  U. Reichert,et al.  13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. , 2000, The Journal of investigative dermatology.

[18]  M. Momoi,et al.  bFGF inhibits the activation of caspase-3 and apoptosis of P19 embryonal carcinoma cells during neuronal differentiation , 1999, Cell Death and Differentiation.

[19]  A. Hendrickx.  Teratogenicity of Retinoids in Rodents, Primates and Humans , 1998 .

[20]  D. Mangelsdorf,et al.  Vitamin A receptors. , 2009, Nutrition reviews.

[21]  R. E. Staples,et al.  Assessment of the effectiveness of animal developmental toxicity testing for human safety. , 1993, Reproductive toxicology.

[22]  H. Spielmann,et al.  Cytotoxicity test using blastocyst-derived euploid embryonal stem cells: a new approach to in vitro teratogenesis screening. , 1991, Reproductive toxicology.

[23]  P. Chambon,et al.  Retinoic acid and synthetic analogs differentially activate retinoic acid receptor dependent transcription. , 1990, Biochemical and biophysical research communications.

[24]  S. Jacob,et al.  Pharmacology of DMSO. , 1986, Cryobiology.

[25]  C. Epstein,et al.  Multiple congenital anomalies in a fetus exposed to 5-fluorouracil during the first trimester. , 1980, American journal of obstetrics and gynecology.

[26]  C. P. Dagg.  Sensitive stages for the production of developmental abnormalities in mice with 5-fluorouracil. , 1960, The American journal of anatomy.